Evidence method
Level · gp.fundamentals.debt_to_revenue
222.87% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
TELA · Mar 31, 2025
TELA Bio, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001558370-25-006994General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.17% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-52.51% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
11.55% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
73.07% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
67.56% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-56.54% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
13.71% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
5.64% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History13 statesHistory building
Jun 30, 20230/8 normalizedLevel 3Sep 30, 20230/8 normalizedLevel 3Dec 31, 20230/8 normalizedLevel 3Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/9 normalizedLevel 3Sep 30, 20240/9 normalizedLevel 3Dec 31, 20240/9 normalizedLevel 3Mar 31, 20250/9 normalizedLevel 3Jun 30, 20258/9 normalizedLevel 3Sep 30, 20257/8 normalizedLevel 3Dec 31, 20257/8 normalizedLevel 3Mar 31, 20267/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 59.34%
- Current
- 222.87%
- Delta
- 163.53%
- Previous
- 1.43%
- Current
- 0.17%
- Delta
- -1.25%
- Previous
- -60.02%
- Current
- -52.51%
- Delta
- 7.51%
- Previous
- 18.56%
- Current
- 11.55%
- Delta
- -7.01%
- Previous
- 18.44%
- Current
- 73.07%
- Delta
- 54.63%
- Previous
- 67.08%
- Current
- 67.56%
- Delta
- 0.48%
- Previous
- -49.23%
- Current
- -56.54%
- Delta
- -7.32%
- Previous
- 12.72%
- Current
- 13.71%
- Delta
- 1.00%
- Previous
- 6.29%
- Current
- 5.64%
- Delta
- -0.66%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · TELA Fundamental State →Has State · TELA Bio, Inc. →Transitioned To · TELA BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · TELA CAPEX_INTENSITY_DECREASED →Transitioned To · TELA CASH_GENERATION_INCREASED →Transitioned To · TELA GROWTH_DECREASED →Transitioned To · TELA INVENTORY_PRESSURE_INCREASED →Transitioned To · TELA MARGIN_INCREASED →Transitioned To · TELA PROFITABILITY_DECREASED →Transitioned To · TELA R_AND_D_INTENSITY_INCREASED →Transitioned To · TELA SBC_INTENSITY_DECREASED →Transitioned To · TELA Fundamental State →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.